Skip to content

Clinical trials

Neoplasm Metastasis trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Not applicable Country / region: United States Clear all

139 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20021
20031
20053
20062
20072
20083
20097
20104
20113
20122
20136
20146
20157
20168
20177
20188
20195
20208
202112
202210
20235
20242
20256
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed79
Recruiting24
Active, not recruiting14
Terminated12
Withdrawn4
Not yet recruiting3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center14
Memorial Sloan Kettering Cancer Center7
Indiana University5
University of California, San Francisco4
University of Washington4
Boston Scientific Corporation3
Cedars-Sinai Medical Center3
Fred Hutchinson Cancer Center3
Jonsson Comprehensive Cancer Center3
Massachusetts General Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis139
Neoplasms26
Breast Neoplasms21
Lung Neoplasms20
Colorectal Neoplasms12
Brain Neoplasms10
Pancreatic Neoplasms10
Prostatic Neoplasms10
Recurrence9
Bone Neoplasms7

Trials

Showing 1 to 25 of 139. Each trial links to its page on Pharma Observatory.

39 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.